Articles related to EYE DISEASES

Infection patients reported using more than ten different brands of artificial tears, and some patients used multiple brands. The majority of patients who used artificial tears said they used EzriCare Artificial Tears, an over-the-counter, preservative-free product packaged in multidose bottles. The outbreak strain was found in opened EzriCare bottles with different lot numbers collected from two states, according to CDC laboratory testing.

After watching or listening to this CME activity hosted by Cynthia Matossian, MD, FACS, Founder and Medical Director at Matossian Eye Associates in Hopewell, NJ, and Jillian Ziemanski, OD, PhD, FAAO, Clinical Assistant Professor at the UAB School of Optometry at the University of Alabama at Birmingham, ophthalmologists and optometrists should be better equipped to analyze clinical trial data supporting the safety and effectiveness of device therapy to treat meibomian gland dysfunction (MGD).

Participants should be better able to discuss anti-VEGF therapy outcomes in patients with moderate-severe and severe nonproliferative diabetic retinopathy after taking part in this educational activity with Drs. Susan Bressler, Mark Dunbar, and Ruth Weinstock, and understand the importance of prompt referral and early diagnosis to reduce or even prevent the vision-threatening complications of diabetes.

New tests of visual function are emerging as a result of recent technology advancements. Today, evaluation of patient populations with limited access to healthcare is made possible by diagnostic testing with portable, affordable technologies, which also allows testing outside of a clinical environment or at home. These modifications make it possible to monitor patients more actively, produce more results, and deliver fast information on the effectiveness of ongoing treatment and prospective changes in visual status. Particularly, functional vision traits such as visual acuity, contrast sensitivity, color vision, binocularity, and others can be easily assessed outside of typical clinic consultations.

Among more than 3,000 patients taking hydroxychloroquine, overall cumulative incidence for developing retinopathy were 2.5% and 8.6% at 10 and 15 years respectively. Incidence was strongly dose-related and most cases were mild.

During pregnancy and the postpartum period, the body is subjected to abnormal stress, raising the possibility of eye and vision-related conditions and complications. Refractive changes, central serous chorioretinopathy, Purtscher-like retinopathy, diabetes, hypertension, and immunologic diseases are examples of eye and vision-related conditions and complications. Although diabetic retinopathy that develops during pregnancy usually resolves on its own after delivery, women are still at risk of progression for up to a year after delivery.